TENtrol Study Launched, aiming Labour Pain Management
The TENtrol study was officially launched with a kick-off meeting at icddr,b, on 19 September 2024 with collaborators from the Obstetrical and Gynaecological Society of Bangladesh (OGSB) and the findings to the forum, AdSEARCH proposed to explore strategic approaches that can translate evidence into activism.
CSO Forum membersʼ representatives actively participated in the discussions. During the session, they explored the way forward, focusing on strengthening advocacy efforts, addressing systemic barriers to implementing the ban, and ensuring accountability in the healthcare, law enforcement and legal sectors.
In addition, AdSEARCH has announced the initiation of the knowledge brief titled “Enforcing the Ban on the TFT” on the journey of banning TFT. The study aims to improve childbirth experiences for women by managing labour pain through the TENS (Transcutaneous Electrical Nerve Stimulation) machines and focuses on the feasibility of introducing TENS devices in health facilities in Bangladesh as a safe, non-invasive, low-cost, and reusable tool. The device operates on the Gate Control Theory of pain and aims to give women greater control over their childbirth experience while reducing the need for unnecessary C-sections.
The study's Principal Investigator Dr Sahar Raza, provided an overview of the research during the event. Along the prominent gynaecologists and Secretary General of OGSB, the AdSEARCH Project Management Team (PMT) also provided valuable insights toward shaping the study's strategic direction. The discussions emphasised the importance of sensitisation workshops with OGSB and at study field sites.
